Literature DB >> 709832

Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders.

W G Yasmineh, G A Ibrahim, M Abbasnezhad, E A Awad.   

Abstract

We determined the total activity and isoenzyme distribution of lactate dehydrogenase and creatine kinase in serum and biopsy specimens from skeletal muscle of nine normal individuals and nine patients with Duchenne muscular dystrophy (I), five with collagen disease (II), and four with non-progressive unclassified myopathy (III). Mean total serum creatine kinase in patients with Duchenne muscular dystrophy (867 U/liter, SD = 197) was 31-fold that in the control group (28 U/liter, SD = 14). There was also a small (3.3-fold) increase in the mean total serum creatine kinase of patients with III, but none in the serum from patients with II. Changes in the creatine kinase isoenzyme distribution of skeletal muscle were primarily in the MB isoenzyme. The mean percentage of creatine kinase-MB activity in muscle from patients with I (2.81, SD = 1.15) and patients with III (1.69, SD = 1.07) significantly (P less than 0.005) exceeded that of the control group (0.43, SD = 0.18). Muscle from patients with II showed little change. The most striking changes in lactate dehydrogenase were also observed in patients with I, in whom the mean total serum activity (356 U/liter, SD = 115) was 3.4-fold that of serum from the control group (105 U/liter, SD = 19). Skeletal muscle from these patients also showed a significant decrease in mean percent isoenzyme 5 activity (from 50 to 23) and an increase in that of isoenzymes 1 and 2 (from 1 to 9 and 8 to 20, respectively). These changes in the distribution of these two sets of isoenzymes in muscle were reflected in the serum.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709832

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 2.  Microelectrophoresis as a tool in enzyme histochemistry.

Authors:  G Huether; V Neuhoff
Journal:  Histochem J       Date:  1981-03

3.  Muscle cell leakage due to long distance training.

Authors:  K N Hansen; J Bjerre-Knudsen; U Brodthagen; R Jordal; P E Paulev
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

4.  Skeletal muscle CK-B activity in neurogenic muscular atrophies.

Authors:  E Vretou-Jockers; D Vassilopoulos
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

5.  Serum Enzyme Profiles Differentiate Five Types of Muscular Dystrophy.

Authors:  Yuling Zhu; Huili Zhang; Yiming Sun; Yaqin Li; Langhui Deng; Xingxuan Wen; Huaqiao Wang; Cheng Zhang
Journal:  Dis Markers       Date:  2015-04-29       Impact factor: 3.434

6.  Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy.

Authors:  Craig M McDonald; Brenda Wong; Kevin M Flanigan; Rosamund Wilson; Sjef de Kimpe; Afrodite Lourbakos; Zhengning Lin; Giles Campion
Journal:  Ann Clin Transl Neurol       Date:  2018-07-11       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.